Key Highlights

  • Net sales were USD 1,942 million versus 1,869 million, and Gross Profit was USD 825 million versus 799 million.
  • Operating profit was USD 160 million versus 191 million, after a USD 236 million loss on Assets held for sale.
  • Net loss from continuing operations was USD 127 million versus income of 99 million; net loss was USD 55 million.
  • Loss per share from continuing operations was USD 0.50 versus income of 0.39; Adjusted Operating EBITDA was USD 403 million.

Net Sales and Gross Profit

International Flavors & Fragrances Inc. (NYSE:IFF) filed its Quarterly Report for the period ended September 30, 2026. Net sales were USD 1,942 million, compared with USD 1,869 million in the third quarter of 2025. Cost of sales was USD 1,117 million versus USD 1,070 million, and gross profit was USD 825 million versus USD 799 million.

For the nine months, net sales were USD 5,802 million versus USD 5,838 million, and gross profit was USD 2,507 million versus USD 2,475 million.

Analyst estimates were EPS of USD 0.81 against reported EPS of USD 0.83, and Revenue of USD 1.91 billion against reported revenue of USD 1.94 billion.

Operating Profit and Net Loss

Research and development expenses were USD 170 million versus USD 162 million, and selling and administrative expenses were USD 387 million versus USD 348 million. Amortization of acquisition-related intangibles was USD 78 million versus USD 84 million. The company recorded a Goodwill Impairment of USD 23 million, restructuring and other charges of USD 5 million versus USD 14 million, and losses on sale of assets of USD 2 million.

Operating profit was USD 160 million versus USD 191 million. Interest expense was USD 46 million versus USD 48 million, and the loss on assets classified as held for sale was USD 236 million. The loss from continuing operations before taxes was USD 134 million versus income of USD 130 million, and the income tax benefit was USD 7 million versus a provision of USD 31 million.

The net loss from continuing operations was USD 127 million versus Net Income of USD 99 million. Net income from discontinued operations was USD 72 million versus a loss of USD 58 million. The net loss attributable to shareholders was USD 55 million versus net income of USD 40 million.

Basic and diluted loss per share from continuing operations was USD 0.50 versus income of USD 0.39, and income per share from discontinued operations was USD 0.28 versus a loss of USD 0.23. The net loss per share, basic, was USD 0.22 versus income of USD 0.16. For the nine months, net income was USD 166 million versus a net loss of USD 377 million.

Adjusted Results, Cash Flow and Balance Sheet

Total Adjusted Operating EBITDA from continuing operations was USD 403 million for the quarter and USD 1,244 million for the nine months. The reconciliation included Depreciation and amortization of USD 156 million, interest expense of USD 46 million, divestiture costs of USD 10 million and strategic initiative costs of USD 9 million.

Net cash provided by Operating Activities for the nine months was USD 820 million versus USD 532 million. Additions to property, plant and equipment were USD 449 million versus USD 406 million, and net proceeds from Business disposals were USD 247 million versus USD 2,707 million.

Cash and cash equivalents were USD 272 million at September 30, 2026, compared with USD 347 million at December 31, 2025. Trade receivables, net, were USD 1,416 million versus USD 1,294 million, inventories were USD 1,452 million versus USD 1,507 million, and assets held for sale were USD 117 million.

Items to Follow

Investors can follow assets held for sale, which were USD 117 million, the USD 236 million loss recorded on assets classified as held for sale, and divestiture costs of USD 10 million in the quarter.

Other items include Adjusted Operating EBITDA of USD 403 million, the results of discontinued operations, and selling and administrative expenses of USD 387 million.